TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $61.3K2010: $220.8K2011: $960.3K2012: $400.8K2013: $2.28M2014: $483.0K2015: $1.24M2016: $2.25M2017: $1.33M2018: $556.0K2019: $440.0K2020: $64.0K2021: $340.0K2022: $413.0K2023: $674.0K2024: $565.0K2025: $522.0K$522.0K
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$522.0K-7.6%
2024$565.0K-16.2%
2023$674.0K+63.2%
2022$413.0K+21.5%
2021$340.0K+431.2%
2020$64.0K-85.5%
2019$440.0K-20.9%
2018$556.0K-58.1%
2017$1.33M-41.0%
2016$2.25M+81.1%
2015$1.24M+156.9%
2014$483.0K-78.8%
2013$2.28M+468.1%
2012$400.8K-58.3%
2011$960.3K+335.0%
2010$220.8K+260.3%
2009$61.3K—